Advice
Discontinuation of docetaxel (Taxotere)
The manufacturer, Sanofi, have confirmed that docetaxel (Taxotere) has been discontinued.
Medicine details
- Medicine name:
- docetaxel (Taxotere) injection concentrate
- SMC ID:
- 333/06
- Indication:
- Metastatic gastric adenocarcinoma
- Pharmaceutical company
- Sanofi-Aventis
- BNF chapter
- Malignant disease and immunosuppression
- Submission type
- Non submission
- Status
- Withdrawn
- Date advice published
- 13 November 2006
Additional notes
The manufacturer, Sanofi, have confirmed that docetaxel (Taxotere) has been discontinued.